Dr. Patel Mahendra Harji

Dr. Mahendra H Patel is a Diabetes Consultant (Specialist) at Patel's Diabetes Care Centre, Thane. He is also Honorary Consultant at BSES Global Hospital, Andheri (West). He obtained the MBBS degree through D Y Patil Medical College, Nerul, in 1996, and a Diploma in Diabetology from B Y L Nair Charitable Hospital and TN Medical College, Mumbai, in 1999.

He has been a Co-Investigator and Clinical Research Associate for several drug studies and the Principal Investigator... [+]

Testimonials

Accreditation

Medical Advisor, Intas Pharmacueticals.
Medical Advisor, Torrent Pharmacueticals.
Medical Advisor, Novartis.

[+]

Medical Advisor, Ranbaxy.
Medical Advisor, Macleods Pharma.
Medical Advisor, Shreya Biotech.
Medical Advisor, Biocon.
Medical Advisor, Novo Nordisk.
Medical Advisor, MSD.
Medical Advisor, Astra Zeneca.
Medical Advisor, Sun Pharmacueticals.
Medical Advisor, USV.
Medical Advisor, Eris Pharmacueticals.
Medical Advisor, Eli Lilly.

[-]

Research

Sub-Investigator & Clinical Research Associate: Insulin Lispro Low Mixture(LM) compared to NPH twice daily in the treatment of Type II Diabetes Mellitus. Eli-Lilly Pvt Ltd.

Protocol ID F3Z-MC-IOMS

Sub-Investigator & Clinical Research Associate: A comparison of Lispro Low Mixture and Huminsulin 30/70 in treatment of Type II Diabetes Mellitus during Ramadhan. Eli-Lilly Pvt Ltd.

Protocol ID: F3Z-MC-IOMV

[+]

Sub-Investigator & Clinical Research Associate: Efficacy of JUAR in reducing fasting plasma glucose in NIDDM patients. Siro Clinpharm Ltd.

Protocol ID: SRF/ SF- K- 0001- 000

Sub-Investigator & Clinical Research Associate IDM 1 Trial: A Double-Blind, Placebo Controlled, Randomized, Phase III, Multicentric study to study the efficacy and safety of IDM I in patients with Type II Daibetes Mellitus on Treatment with Sulphonylureas. Indus Pharma Ltd. & Siro Clinpharma Pvt Ltd.

Protocol ID: SCP-IBP-2001-02

Phase I (Feasibility Study), Sub-Investigator Implantable Glucose Sensor Trial.: A Study of Safety and effectiveness of Dexcom continous glucose monitoring in Patients with Type I Daibetes Mellitus. Dexcom Ltd ( USA).

Protocol ID: G10-02-01

Sub-Investigator and Clinical Research Associate Gourdin Trial: Efficacy and Safety of Gourdin in subjects with Type II Diabetes Mellitus who remain on concomitant oral or combined bedtime Insulin and oral treatment. A prospective Randomised, Parallel designed, Placebo controlled, Double-Blind Trial. Pfizer International & Diagnosearch.

Protocol ID: A 5011001.

Principal-Investigator, Phase IV Study: Effectiveness of Huminsulin 30/70 in Type II Diabetes Mellitus Patients who are uncontrolled on oral Anti Diabetic drugs. Eli-Lilly Pvt Ltd.

Principal Investigator, Phase IV Study: Effectiveness of Rosiglitazone in Type II Diabetes Mellitus and its Adverse effects. Dr Reddy’s Lab.

[-]

Testimonials

Accreditation

Research

PERSONAL INFORMATION:

NON-PERSONAL INFORMATION:

Testimonials

Accreditation

Ailments

Research